chrisvoncsefalvay/vaers-outcomes huggingface dataset:
after receiving the third dose booster of the covid 19 vaccine from Pfizer noticed hair loss/ alopecia; His skin md diagnosed him "alopecia aerate; This is a spontaneous report received from contactable reporter(s) (Other HCP and Consumer or other non HCP), Program ID: (141003).  A 63-year-old male patient received BNT162b2 (BNT162B2), as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (DOSE 1, Unknown Manufacturer), for COVID-19 Immunization; Covid-19 vaccine (DOSE 2, Unknown Manufacturer), for COVID-19 Immunization. The following information was reported: ALOPECIA (non-serious), outcome "unknown", described as "after receiving the third dose booster of the covid 19 vaccine from Pfizer noticed hair loss/ alopecia"; ALOPECIA AREATA (non-serious), outcome "unknown", described as "His skin md diagnosed him "alopecia aerate". Therapeutic measures were taken as a result of alopecia, alopecia areata.  Additional info: Patient started of therapy on 28Apr2022 for alopecia aerate (XELJANZ, 10 mg, twice a day, oral, from 28Apr2022).  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
L upper arm, red, swollen and indurated 24 hrs later when pt was seen in the clinic for work related bloodwork.
COVID-19 TESTED POSITIVE; This spontaneous report received from a patient concerned a White Hispanic or Latino male of unspecified age, race, and ethnicity. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of administration not reported, batch number: 1805029, expiry: 23-AUG-2021) dose was not reported, dose number in series was 1, 01 in total was administered on 14-MAR-2021 to left arm for prophylactic vaccination. No adverse events were reported following vaccination with covid-19 vaccine ad26.cov2.s. The patient additionally received non-company suspect vaccine included: BNT 162 (Pfizer) (form of administration, route of administration, and batch number were not reported) dose was not reported, dose number in series was 2, administered on 03-DEC-2021 for prophylactic vaccination.  Patient received unspecified concomitant medications. On 23-JAN-2022, following vaccination with BNT 162, the patient tested positive with Bi Nax Now antigen take home test (coronavirus disease-19 test positive). Laboratory data included: COVID-19 antigen test (NR: not provided) positive. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of covid-19 tested positive was not reported (dose number in series was 2). This report was non-serious.
PRESSURE IN THE HEAD; SORENESS ALL OVER/PAIN; NO TASTE; NO APPETITE; FEVER; BAD HEADACHE; This spontaneous report received from a patient concerned a 53 year old male. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 207A21A, expiry: UNKNOWN) dose was not reported, administered on 10-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 10-APR-2021, the subject experienced bad headache. On 10-APR-2021, the subject experienced fever. On 10-APR-2021, the subject experienced pressure in the head. On 10-APR-2021, the subject experienced soreness all over/pain. On 10-APR-2021, the subject experienced no taste. On 10-APR-2021, the subject experienced no appetite. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from bad headache, fever, pressure in the head, soreness all over/pain, no taste, and no appetite. This report was non-serious.
The patient woke up from sleep with neck and shoulder pain 5 weeks ago.  As of today he remains with weakness in the left upper arm.
Few minutes after the vaccine had crazy fast afib, my heart was racing out of control for a few minutes, dizziness and weakness followed, next day dizzy and close to passing out several times, couldn?t drive a car, chest pressure, couldn?t get a good breath, fatigue, 48 hours later just starting to get back some strength but still feel off.
This spontaneous report was received from the Vaccine Coordinator referring to a 18 years old patient of unknown gender. The patient's medical history, concurrent conditions, concomitant medications, and historical drugs were not reported. On 11-SEP-2017, the patient was vaccinated with an improperly stored dose of VARIVAX with one of these lot #'s reported M017292, expiration date on 07-APR-2018; lot # N017701, expiration date on 09-JUN-2019 or with lot # N019127, expiration date on 22-JUN-2019 (Strength, route, dose, frequency, and anatomical location were unknown) for prophylaxis. There was no adverse effect reported. The administered dose of vaccine experienced the temperature excursion of 7.52 F degrees Fahrenheit for 24 hour, and had a previous temperature excursion of 5.5 F degrees Fahrenheit for 1 hour. There was a digital data logger involved. This is one of several reports received from the same reporter; Sender's Comments: US-009507513-1709USA008693.
Pt recvd 3 doses of Engerix-B vax & following 3rd dose exp cramps, diarrhea x4 hrs & lethargy next day & was determined to be a non-responder; pt exp same sx w/1st & 2nd dose of vax;
Patient was given the incorrect type of covid vaccine as his second primary dose. Patient started series with Moderna monovalent, however was given Pfizer monovalent as second vaccine. Primary series should not be mixed.
Child developed unexplained pain in right leg and refusal to walk, worsened over subsequent day and then developed a dermatome-distributed herpetiform rash on the leg.  I presume this to be herpes zoster related to his varicella vaccine (simplex not ruled out but no history to suggest it).  I have started him on acyclovir today and will follow his progress.
Rash at injection site  started 9-15-21 and swollen lymph node by left collar bone 9-14-21
5 minutes after receiving vaccine became warm and clammy. Thought it was hot flash. Hx of HBP. BP 180/120 HR 86 and Pulsox99 started felling better and BP 174/110 but then began with chest tightness and warmth. Very clammy as well. Very anxious initially at entrance because had reactions of tongue thickness with loss of taste for one week after both Pfizer vaccines. 911 called and pt transported to hospital
Coughing; Sneezing; Head cold; Headache; Chills; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of COUGH (Coughing), SNEEZING (Sneezing), NASOPHARYNGITIS (Head cold), HEADACHE (Headache) and CHILLS (Chills) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 25-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-May-2021, the patient experienced COUGH (Coughing), SNEEZING (Sneezing), NASOPHARYNGITIS (Head cold), HEADACHE (Headache) and CHILLS (Chills). The patient was treated with AZITHROMYCIN (Z-PAK) at an unspecified dose and frequency. At the time of the report, COUGH (Coughing), SNEEZING (Sneezing), NASOPHARYNGITIS (Head cold), HEADACHE (Headache) and CHILLS (Chills) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient received their first dose of Moderna vaccine and on 26-May-2021, the patient had coughing, sneezing, headache, chills, and a head cold. On 30-May-2021, the patient visited the emergency room walk-in clinic where a Health care professional gave the patient a Z-pack of antibiotics. On the next day, the patient felt better but the symptoms were still present at the time of reporting.  No Concomitant product use was reported.
Vaccinee experienced pruritus 2 days post 2nd Engerix-B inject (1st inject was rec'd 1 month prior to 2nd dose & was uneventful). Tx: Antipsychotics & a referral to a psychiatrist. MD has described event as permanently disabling.
headache; body aches; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team.  A 65-year-old male patient received bnt162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: HEADACHE (non-serious), outcome "not recovered"; PAIN (non-serious), outcome "not recovered", described as "body aches". The information on the batch/lot number for bnt162b2 omi xbb.1.5 has been requested and will be submitted if and when received.
This spontaneous report was received from a female patient of unknown age. The patient's medical history, concurrent conditions, concomitant medications, and historical drugs were not reported. In approximately 2016 (reported as "about 2 years ago"), the patient was vaccinated with an unspecified pneumococcal vaccine, polyvalent (23-valent)(route, dose, frequency, anatomical location, lot # and expiration date were unknown) for prophylaxis (reported as " to avoid pneumonia"). On approximately 02-MAR-2017(reported as "3 weeks ago"), the patient reported that she thought she had the flu and visited an unspecified hospital which said she tested negative for flu, and an X-Ray was performed to the patient that showed pneumonia in her right lung. At the time of the report, the patient stated she was fine. She did not provide the name of her physician or the hospital that diagnosed her with pneumonia. The patient did not mention the causality assessment between the event of pneumonia, and the unspecified pneumococcal vaccine, polyvalent (23-valent). Upon internal review, pneumonia was determined to be medically significant.
This case was reported by a nurse via call center representative and described the occurrence of inappropriate age at vaccine administration in a 16-mont-old male patient who received KINRIX (batch number 54L2R, expiry date 23rd September 2016). On an unknown date, the patient received the 4th dose of KINRIX (intramuscular) .5 ml. On an unknown date, the dose was an unknown dose. On an unknown date, an unknown time after receiving KINRIX, the patient experienced inappropriate age at vaccine administration. On an unknown date, the outcome of the inappropriate age at vaccine administration was unknown. Additional information: KINRIX was administered to 16month old child instead of just a DTaP vaccine.
Patient had dizziness, anxious (didn't have breakfast). Given juice, water, crackers. Dizziness resolved, patient stable, released from vaccination site.
4-26-13 had a temp of 100.9 in office during vaccines. Pt. was on children's TYLENOL and children's MOTRIN as needed. Later that day fever increased.  Temp went up last night to 103, was 103 this morning when waking up, TYLENOL given this morning. Runny nose yes, slight, clear. No nasal congestion. No coughing. No poor appetite, eating well and drinking well. No sleeping poorly, sleeping well.
Chest pain, shortness of breath  Hospitalized 4 days dx  enlarged heart, heart failure Rx coreg, lasix
She started to feel sick on 01Apr; she received her first vaccine dose on 31Mar. She started to feel sick on 01Apr and then tested positive for covid.; she received her first vaccine dose on 31Mar. She started to feel sick on 01Apr and then tested positive for covid.; This is a spontaneous report from a contactable consumer. This female consumer (patient) of an unspecified age received her first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: unknown) via an unspecified route of administration on 31Mar2021 at single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. On 01Apr2021, she started to feel sick and then on an unspecified date in Apr2021, she tested positive for covid. She reported that she was scheduled for her second vaccine dose the next day and asked if it was advisable to get the second vaccine dose as planned. The outcome for the events was unknown.  Information on lot number/batch number has been requested.
having a little headache; This is a spontaneous report from a contactable other hcp.A 65-years-old male patient received bnt162b2 (BNT162B2, formulation: solution for injection, Batch/Lot number was not reported), dose 2 via an unspecified route of administration on 24Feb2021 (at the age of 65 years) as 2ND DOSE, SINGLE DOSE for covid-19 immunisation. Medical history included rheumatoid arthritis from 1996 having swollen joint, stiff tendons, arm, and legs, and liquid in his knee, stress being a factor of rheumatoid arthritis.The patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/lot number and Expiration date not reported) via an unspecified route of administration, on 21Jan2021 (at the age of 65 years) as a single dose for COVID-19 immunisation. Concomitant medication(s) included tofacitinib citrate (XELJANZ XR, 11mg, oral) taken for rheumatoid arthritis from 2017 and ongoing; methotrexate (METHOTREXATE) taken for an unspecified indication, start and stop date were not reported; adalimumab (HUMIRA) taken for an unspecified indication, start and stop date were not reported; etanercept (ENBREL) taken for an unspecified indication, start and stop date were not reported. On an unspecified date in 2021,the patient experienced having a little headache. Patient reported stress being a factor of rheumatoid arthritis. Patient reported having pain, but it was not unbearable. Patient reported having discomfort in his wrist when it was cloudy, and when it snows.The patient underwent lab tests and procedures which included sars-cov-1 test: negative on an unspecified date. The outcome of event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
This spontaneous report as received from a registered nurse refers to a 60 year old female patient. On 28-APR-2014 the patient was vaccinated with ZOSTAVAX (lot # J000853, expired at 23-APR-2014, 19400 PFU, 0.5 ml, subcutaneous). No concomitant medications and no other relevant medical history were reported. The reporter stated that on 28-APR-2014 the patient received an expired vaccine. The patient received a 0.5 ml of ZOSTAVAX. No adverse effects were reported. No other relevant medical information was reported. Additional information has been requested.
That morning, I noticed there was blood in my urine. It was pinkish. As the day progressed, I thought I was on my period because the bleeding got worse. I left work and went to urgent care. They took a urine sample. The nurse asked me if I had taken AZO. I said no. The doctor said the test was inconclusive because it is a color changing test and there was too much blood. He said he was going to treat me for an infection regardless. They also did a kidney panel. The test came back normal. They prescribed antibiotics. The bleeding lasted for about a day and a half. I've had additional urine tests. They've seen some red blood cells in my urine.
Severe migraine, lasting 3 days, culminating in vomiting.  Patient was 21 weeks pregnant at time of adverse event. Estimated delivery date September 10, 2021.
The patient had a low grade fever on the day of the vaccination. The patient's left arm was red, warm and painful. On 10/17/2001 the patient is afebrile, playful, his arm is still warm but soft and natural feeling. Grandmother to call the Health Dept in a few days to report the patient's condition.
PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE ACUTE RESPIRATORY FAILURE CHRONIC HYPERCAPNIC RESPIRATORY FAILURE ACUTE ON CHRONIC HYPERCAPNIC RESPIRATORY FAILURE 2/24/2022 -- RECURRENCE OF SAME SYMPTOMS
The same afternoon of the shot her arm started turning red and warm with a raised bump on it at injection site. It has been 2 days and still having redness and itching with warmth. I told her to ice it and use BENADRYL cream or BENADRYL capsules. When I called her back later on in the afternoon she had used both and has went down a little. If still bad Saturday will go to the doctor to have it checked.
This spontaneous report was received from a registered nurse referring to a 11 year old male patient. The patient's concurrent conditions and medical history were not provided. The patient did not have drug reactions or allergies. On 02-DEC-2005, the patient was vaccinated with a first dose of VARIVAX (Merck), and 13-AUG-2015 he was vaccinated with the second dose of VARIVAX (Merck) (strength, dose, route, anatomical location, lot number and expiration date were not provided). The patient did not take any concomitant medications. The nurse reported that since an unspecified date, (over the past several years), the patient was complaining of abdominal pain, subsequently, on 02-DEC-2015, the patient was hospitalized for 48 hours, where an appendectomy, requiring intubation was performed. During the procedure, a biopsy was performed which showed a chronic inflammation with occasional granuloma; due to this finding, the patient was diagnosed with Crohn's Disease (the patient would began an unspecified immunosuppressive therapy agent in the near future). It was also reported, that due to negative titers, the patient was administered a third dose of VARIVAX (Merck) on 22-DEC-2015. The nurse considered the event of appendectomy to be serious event, as it required intubation during surgery. At the time of the report, the patient had not recovered from the adverse events. Additional information has been requested.
5FEB cough & runny nose & fever;6FEB T101 & 102, irritable;7FEB swollen cheeks;10PM T104, T101, diarrhea, jerking;8FEB diarrhea, temp;9FEB T102;
Information has been received from a physician concerning a 15 year old male who on 11/20/03, was vaccinated with the first dose of varicella virus vaccine live. The physician reported that on 12/03/03 the pt developed a rash consisting of 5-7 lesions on his trunk. The physician considered the rash to be a mild form of chickenpox. Unspecified medical attention was sought, but it was unknown if treatment was required. At the time of this report, the outcome was unknown. Additional information has been requested.
Within a week started to have severe pain left shoulder and inability to lift shoulder above 90 degrees due to pain - still ongoing but improving and first brought to provider attention at visit today.  Referred to physical therapy.
Fever; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number was unknown), via an unspecified route of administration on 28Dec2020 09:00 at single dose for covid-19 immunization. The patient had no medical history. The patient's concomitant medications were not reported. The patient calling concerning the vaccination, the patient received vaccination on this past Tuesday which was 28Dec2020 and the patient had recently just recovered from Covid and the patient asked the person giving her/him the vaccination it was okay since the patient just recovered from Covid to have it. She said yes. The patient could have it. Since last Tuesday (28Dec2020) the patient got the vaccination at 9 AM in the morning. The patient did fine all during the day. That night the patient started to run fever (in Dec2020) and the patient kept on fever all of that night, yesterday (30Dec2020) and today (31Dec2020) and the patient was just curious if this was normal. Yesterday (30Dec2020) because the patient thought may be she/he should go have the test again for Covid, the patient's normal nurse practitioner, doctor said no, but the patient probably shouldn't take the second vaccine, so that's what the patient's question is and the patient what to know if there are going to have an adverse reaction. The patient underwent laboratory test included only the Covid test on an unspecified date. The outcome of the event was unknown. Information on lot/batch number has been requested.
Initial information received on 14-Jun-2018 regarding an unsolicited valid non-serious case received from Nurse. This case involves an 18 years old male patient who received a dose on 13 Jun 2018 that had expired on 16 Jan 2018/ no side effects were noted, while he received vaccine MENACTRA. The patients past medical history, concomitant medication and family history were not provided. Patient had no other vaccines. On 13-Jun-2018, the patient received a dose of suspect MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE lot U5460BA, expiry date 16 Jan 2018 via unknown route in unknown administration site. It was an actual medication error due to Expired vaccine used. Patient did not experience any adverse reaction after the injection. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error. List of documents held by sender- none.
blacked out 20min p/shot felt tired, different, lt hand, arm purple x 5min;BP, HR fine @ MD visit;
EXTREMELY HUNGRY ALL DAY; RECEIVED A VACCINE THAT WAS STORED IN THE REFRIGERATOR BEYOND THE RECOMMENDED STORAGE TIME (OVER NIGHT, POTENTIALLY BETWEEN 12-24 HOURS); This spontaneous report received from a patient concerned a 46 year old male. The patient's weight was 175 pounds, and height was 69 inches. The patient's concurrent conditions included: non smoker, non alcohol user, high blood pressure, asthma, seasonal allergies, cat allergy, soap allergy, dog allergy, horses allergy, hay allergy, and fresh cut grass allergy, and other pre-existing medical conditions included: The patient have no history of drug abuse or illicit drug usage. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 203AZ1A, expiry: UNKNOWN) dose was not reported, administered on 05-JUN-2021 11:00 for prophylactic vaccination. Concomitant medications included fexofenadine hydrochloride for drug used for unknown indication, glimepiride for drug used for unknown indication, losartan for drug used for unknown indication, and atenolol. On 05-JUN-2021, the patient experienced extremely hungry all day. On 05-JUN-2021, the patient experienced received a vaccine that was stored in the refrigerator beyond the recommended storage time (over night, potentially between 12-24 hours). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from extremely hungry all day on 12-JUN-2021, and the outcome of received a vaccine that was stored in the refrigerator beyond the recommended storage time (over night, potentially between 12-24 hours) was not reported. This report was non-serious.